Country Risk Implications of Middle East Conflict Escalation
Examining the impact of conflict escalation in the Middle East on Gulf states' investment profiles and conflict-risk assessments.
As Biopharma Turns to China for Growth, ESG Risks Remain in Focus
Examining how investors can evaluate the ESG and geopolitical risks that increasingly accompany partnerships between Chinese biopharma companies and Western drugmakers.
Expanding ESG Transparency in Private Markets
This report examines ESG risk in private markets via the Morningstar Pitchbook Unicorn 30 Index and Sustainalytics' Controversy Ratings.
Transition or Illusion? What Capital Flows Reveal About Net Zero Credibility
Examining what capital flows reveal about transition credibility, linking corporate capex decisions directly to real-world climate outcomes.
